Related Experiment Video
Updated: Sep 9, 2025

08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.5K
[Chimeric antigen receptor T-cells for patients with hematologic malignancies]
Maria-Luisa Schubert1, Peter Dreger1, Michael Schmitt2
1Medizinische Klinik V (Hämatologie, Onkologie und Rheumatologie), Deutsches Konsortium für Tumorerkrankungen (DKTK) und Nationales Zentrum für Tumorerkrankungen (NCT), Universitätsklinikum Heidelberg (UKHD), Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland.
Zeitschrift Fur Rheumatologie
|September 4, 2025
Summary
Chimeric antigen receptor (CAR) T-cell therapy is now standard for B-cell diseases like leukemia and lymphoma. Expertise has improved treatment, with wider applications expected beyond blood cancers.
Area of Science:
- Immunotherapy
- Cell and Gene Therapy
- Oncology

